Balo Andrew K Insider Trading Activity

Average Profitability
227.27%
Insider Buys Quantity
1
Insider Buys Sum
$10,719.60
Insider Sells Quantity
102
Insider Sells Sum
$57.56M

Insider Activity of Balo Andrew K

Biography of Balo Andrew K

No biography is available at this moment.

2021-09-09SaleDexCom, Inc.
DXCM
*
5,597
0.0057%
$546.78$3.06M-22.49%
2021-08-03SaleDexCom, Inc.
DXCM
*
2,757
0.0028%
$515.87$1.42M-7.51%
2021-07-06SaleDexCom, Inc.
DXCM
*
2,974
0.003%
$430.14$1.28M+11.28%
2021-06-03SaleDexCom, Inc.
DXCM
*
2,391
0.0025%
$375.00$896,625+30.14%
2021-03-10SaleDexCom, Inc.
DXCM
*
5,566
0.0059%
$362.92$2.02M+25.57%
2020-09-15SaleDexCom, Inc.
DXCM
*
5,256
0.0055%
$397.35$2.09M-2.67%
2020-09-09SaleDexCom, Inc.
DXCM
*
4,580
0.0047%
$398.30$1.82M-3.61%
2020-06-15SaleDexCom, Inc.
DXCM
*
6,522
0.0064%
$366.47$2.39M-2.93%
2020-04-15SaleDexCom, Inc.
DXCM
*
6,690
0.0069%
$283.39$1.9M+32.19%
2020-03-11SaleDexCom, Inc.
DXCM
*
8,161
0.0093%
$264.82$2.16M+51.65%
2019-09-18SaleDexCom, Inc.
DXCM
*
2,386
0.0025%
$151.46$361,384+75.89%
2019-09-09SaleDexCom, Inc.
DXCM
*
9,107
0.0104%
$151.56$1.38M+83.27%
2019-09-03SaleDexCom, Inc.
DXCM
*
37
<0.0001%
$170.00$6,290+48.86%
2019-06-05SaleDexCom, Inc.
DXCM
*
7,825
0.0087%
$125.00$978,125+73.15%
2019-03-12SaleDexCom, Inc.
DXCM
*
10,917
0.012%
$142.79$1.56M+7.23%
2018-12-14SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,000
0.0057%
$121.23$606,167+21.84%
2018-11-14SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,000
0.0058%
$143.13$715,664+4.7%
2018-10-12SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,000
0.0056%
$124.79$623,934+11.85%
2018-09-14SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,000
0.0057%
$145.17$725,851-2.57%
2018-09-10SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,587
0.0063%
$143.76$803,160-3.97%
Total: 103
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.